Friday, January 23, 2026

‘More of an Instinct’: Trump Explains How He’ll Decide Which Companies Get Tariff Exemptions

President Donald Trump revealed Wednesday he may grant exemptions to certain companies hurt by his sweeping tariffs based primarily on his “instinct” rather than established economic analysis.

“You almost can’t take a pencil to paper. It’s really more of an instinct than anything else,” Trump told reporters during a press conference with Treasury Secretary Scott Bessent. “Some companies, through no fault of their own, they happen to be in an industry that is more affected by these things than others.”

The vague process, without established guidelines or oversight, creates a situation where companies may need to appeal directly to the administration for relief. Trump’s statement that “you have to be able to show a little flexibility, and I’m able to do that” suggests a personalized approach to exemptions that could advantage businesses with stronger connections to the White House.

The administration has already carved out exemptions for approximately $644 billion in imports following Trump’s “Liberation Day” tariff announcements, which imposed a 10% universal tariff on imported goods plus higher “reciprocal” tariffs targeting China and European Union countries. 

The Wall Street Journal reports $185 billion of these exemptions benefit goods from Canada and Mexico, though these nations face other trade restrictions.

Trump’s approach to trade policy has introduced significant uncertainty for businesses. His metaphorical explanation about needing to go “under the wall, around the wall or over the wall” when obstacles appear did little to clarify his decision-making process, instead highlighting the unpredictable nature of the exemption system.

Pharmaceutical companies, temporarily exempted while undergoing a Section 232 investigation, may soon face what Trump described as “a major tariff” despite the ongoing review. At a National Republican Congressional Committee dinner Tuesday night, Trump indicated pharmaceutical tariffs would be announced “very soon,” suggesting the investigation’s outcome may already be predetermined.

Related: Kimbal, Elon Musk’s Brother, Calls Out Trump For “Permanent Tax” On US Consumer


Information for this story was found via the sources and companies mentioned. The author has no securities or affiliations related to the organizations discussed. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Moon River Moly: The Davidson Moly-Copper-Tungsten PEA

Integra: The DeLamar Heap Leach Feasibility Study

Highlander Silver: The Saviour Of Bear Creek Mining

Recommended

Steadright Subsidiary NSM Capital Sarl Applies For License At Titanbeach One

Goliath Resources Accelerates Option Agreement On Golddigger While Reducing NSR

Related News

Trump Signals Openness to China Deal as November 1 Tariff Deadline Looms

President Donald Trump indicated over the weekend he remains confident in reaching a trade agreement...

Tuesday, October 21, 2025, 12:17:00 PM

‘Trumpism Without Trump’: New Poll Shows Republicans Are Ditching Trump For DeSantis

“There’s a new Republican sheriff in town,” said David Paleologos, director of the Suffolk University...

Wednesday, December 14, 2022, 11:00:00 AM

Is the 30% Foreign Withholding Tax Making a Comeback?

Talk of reinstating a 30% withholding tax on foreign holders of US financial assets has...

Wednesday, April 9, 2025, 02:17:00 PM

Canada’s Auto Production Hits 3-Decade Low Amid Trump Tariff War

Canada’s automotive production plummeted to its lowest level in more than 30 years as escalating...

Tuesday, July 22, 2025, 10:52:00 AM

Trump Targets Defense Contractors Over Buybacks

President Donald Trump escalated pressure on US defense contractors by tying capital return policies and...

Thursday, January 8, 2026, 11:24:00 AM